Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up
- 1 September 2002
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 15 (8) , 387-392
- https://doi.org/10.1111/j.1432-2277.2002.tb00186.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2Transplantation, 1998
- MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-ASSOCIATED NEPHROTOXICITYTransplantation, 1998
- Chronic renal allograft rejection: Immunologic and nonimmunologic risk factorsKidney International, 1996
- Nonimmunologic causes of late renal graft lossKidney International, 1995
- Chronic transplant rejectionKidney International, 1994
- Histopathologic findings associated with a chronic, progressive decline in renal allograft functionKidney International, 1991
- PROTEINURIA FOLLOWING TRANSPLANTATIONTransplantation, 1984
- CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: ONE-YEAR FOLLOW-UP OF A MULTICENTRE TRIALThe Lancet, 1983
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983